ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 35
| Issue : 3 | Page : 1248-1254 |
|
Prevalence of metabolic syndrome in school-aged obese children
Soheir S Abou El-Ella1, Maha A Tawfik1, Zeinab S Abou Zouna1, Mohamed A Abdo Al-Fiqi2
1 Department of Pediatrics, Faculty of Medicine, Menoufia University, Menoufia, Egypt 2 Department of Pediatrics, Sidi Salem Central Hospital, Kafr El-Sheikh Governorate, Egypt
Correspondence Address:
Mohamed A Abdo Al-Fiqi Sidi Salem Center Hospital, Kafr El-Sheikh Governorate, Ezbet Hassan El-Feky Egypt
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/mmj.mmj_313_21
|
|
Objective
To evaluate the prevalence of metabolic syndrome (MS) in a group of school-aged obese children of both sexes.
Background
Data about MS in children are limited in Egypt as the prevalence and magnitude of obesity among school-aged children has been increasing dramatically. We examined the effect of varying degrees of obesity on the prevalence of the MS.
Patients and methods
This cross-sectional study was conducted on obese children (BMI ≥ 95th percentile), aged 6–16 years. Detailed history taking with family pedigree; complete systemic examination; anthropometric measurements, including weight (kg) on Z score, height (m) on Z score, waist circumference (cm), hip circumference (cm), waist-to-height ratio, waist-to-hip ratio, and BMI on Z score; and laboratory investigations such as kidney function tests (urea and creatinine), fasting blood glucose, estimation of glycosylated hemoglobin, liver function tests (alanine transaminase and aspartate aminotransferase), lipid profile (low-density lipoprotein, high-density lipoprotein, and triglyceride), and serum fasting insulin were done.
Results
The prevalence of the MS was 7% among the studied obese children. The mean triglyceride and cholesterol (mg/dl) levels were 132.4 ± 47.2 and 176 ± 37.4, respectively. The mean insulin (mmol/l) and alanine transaminase (IU/l) were 17.5 ± 10.4 and 27.5 ± 18.3, respectively. The mean aspartate aminotransferase (IU/l) and low-density lipoprotein (mg/dl) were 46.2 ± 53.1 and 94.1 ± 35.9, respectively.
Conclusion
MS is prevalent even in young children, so we suggest screening programs for children aged 6–16 years to control obesity and MS in the developing world.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|